Ultromics is a pioneer in AI-driven cardiology diagnostics solutions, offering the first FDA-cleared, Medicare-reimbursed AI technology to help clinicians detect Heart Failure with Preserved Ejection Fraction (HFpEF) and cardiac amyloidosis.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €55 M | Jul, 2025 | series-c |
Industries
Frequently Asked Questions
What industries does Ultromics operate in?
Ultromics operates in the following industries: Healthcare, AI, Cardiology.
When was Ultromics founded?
Ultromics was founded on 2025-07-31.
How much total funding has Ultromics raised?
Ultromics has raised a total of $55,000,000.
Who are the investors in Ultromics?
The investors in Ultromics are: Oxford Science Enterprises, GV, Blue Venture Fund, University of Chicago Medicine, UPMC Enterprises, Lightrock, Allegis Capital.
Who are the founders of Ultromics?
The founders of Ultromics are: PhD.